114 related articles for article (PubMed ID: 37620180)
1. An analysis of the impact of different levels of inspiratory volume using active breathing control on the intrafraction motion and dose coverage of target volumes in patients undergoing thoracic radiotherapy.
Hui MCM; Chiu G; Wong S; Lien SL
J Med Imaging Radiat Sci; 2023 Dec; 54(4):653-661. PubMed ID: 37620180
[TBL] [Abstract][Full Text] [Related]
2. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
[TBL] [Abstract][Full Text] [Related]
3. Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy.
Li R; Han B; Meng B; Maxim PG; Xing L; Koong AC; Diehn M; Loo BW
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):917-23. PubMed ID: 24113060
[TBL] [Abstract][Full Text] [Related]
4. Intrafraction 4D-cone beam CT acquired during volumetric arc radiotherapy delivery: kV parameter optimization and 4D motion accuracy for lung stereotactic body radiotherapy (SBRT) patients.
Liang J; Lack D; Zhou J; Liu Q; Grills I; Yan D
J Appl Clin Med Phys; 2019 Dec; 20(12):10-24. PubMed ID: 31675150
[TBL] [Abstract][Full Text] [Related]
5. Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy.
Rossi MM; Peulen HM; Belderbos JS; Sonke JJ
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):835-43. PubMed ID: 27131084
[TBL] [Abstract][Full Text] [Related]
6. Reduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH.
Gong G; Wang R; Guo Y; Zhai D; Liu T; Lu J; Chen J; Liu C; Yin Y
Radiat Oncol; 2013 Dec; 8():291. PubMed ID: 24359800
[TBL] [Abstract][Full Text] [Related]
7. The use of active breathing control (ABC) to reduce margin for breathing motion.
Wong JW; Sharpe MB; Jaffray DA; Kini VR; Robertson JM; Stromberg JS; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):911-9. PubMed ID: 10386650
[TBL] [Abstract][Full Text] [Related]
8. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
[TBL] [Abstract][Full Text] [Related]
9. [Influence of active breathing control on the dose distribution in the target of forward whole-breast intensity-modulated radiotherapy after breast conserving surgery].
Li JB; Wang JG; Lu J; Xu M; Shao Q; Fan TY; Ma ZF; Sun T; Liang CQ
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):617-21. PubMed ID: 20021951
[TBL] [Abstract][Full Text] [Related]
10. A stochastic control approach to intrafraction motion management in intensity-modulated radiotherapy.
Salari E; Mazur T; Sharp G
Phys Med Biol; 2023 Apr; 68(8):. PubMed ID: 36944246
[No Abstract] [Full Text] [Related]
11. Impact of intrafraction and residual interfraction effect on prostate proton pencil beam scanning.
Tang S; Deville C; Tochner Z; Wang KK; McDonough J; Vapiwala N; Both S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1186-94. PubMed ID: 25442043
[TBL] [Abstract][Full Text] [Related]
12. DMLC tracking and gating can improve dose coverage for prostate VMAT.
Colvill E; Poulsen PR; Booth JT; O'Brien RT; Ng JA; Keall PJ
Med Phys; 2014 Sep; 41(9):091705. PubMed ID: 25186380
[TBL] [Abstract][Full Text] [Related]
13. Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique.
Zhang GG; Ku L; Dilling TJ; Stevens CW; Zhang RR; Li W; Feygelman V
Radiat Oncol; 2011 Nov; 6():152. PubMed ID: 22070866
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric Impact of Intrafraction Motion in Online-Adaptive Intensity Modulated Proton Therapy for Cervical Cancer.
Berger T; Godart J; Jagt T; Vittrup AS; Fokdal LU; Lindegaard JC; Kibsgaard Jensen NB; Zolnay A; Reijtenbagh D; Trnkova P; Tanderup K; Hoogeman M
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1580-1587. PubMed ID: 33227442
[TBL] [Abstract][Full Text] [Related]
15. ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT.
Bellec J; Arab-Ceschia F; Castelli J; Lafond C; Chajon E
Radiat Oncol; 2020 Mar; 15(1):54. PubMed ID: 32127010
[TBL] [Abstract][Full Text] [Related]
16. On the validity of density overrides for VMAT lung SBRT planning.
Wiant D; Vanderstraeten C; Maurer J; Pursley J; Terrell J; Sintay BJ
Med Phys; 2014 Aug; 41(8):081707. PubMed ID: 25086517
[TBL] [Abstract][Full Text] [Related]
17. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion.
Tanyi JA; He T; Summers PA; Mburu RG; Kato CM; Rhodes SM; Hung AY; Fuss M
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1579-85. PubMed ID: 20472357
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
19. Simulated multileaf collimator tracking for stereotactic liver radiotherapy guided by kilovoltage intrafraction monitoring: Dosimetric gain and target overdose trends.
Poulsen PR; Murtaza G; Worm ES; Ravkilde T; O'Brien R; Grau C; Høyer M; Keall P
Radiother Oncol; 2020 Mar; 144():93-100. PubMed ID: 31786423
[TBL] [Abstract][Full Text] [Related]
20. Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: A dosimetric and treatment efficiency analysis.
McGrath SD; Matuszak MM; Yan D; Kestin LL; Martinez AA; Grills IS
Radiother Oncol; 2010 May; 95(2):153-7. PubMed ID: 20116115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
